Smart Drug Delivery Systems Based on Cyclodextrins and Chitosan for Cancer Therapy

Larisa Păduraru1, Alina-Diana Panainte1, Cătălina-Anișoara Peptu2

  • 1Department of Analytical Chemistry, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy from Iasi, 16th Universitatii Street, 700116 Iasi, Romania.

Insights

Novel nanodelivery systems using cyclodextrins (CDs) and chitosan (CS) enhance antitumor drug efficacy. These smart systems target cancer sites by responding to stimuli like pH, improving drug delivery and reducing toxicity.

Area of Science:

  • Oncology
  • Materials Science
  • Nanotechnology

Background:

  • Conventional cancer therapies face limitations including poor targeting, drug resistance, and toxicity.
  • Developing advanced drug delivery systems is crucial for improving cancer treatment outcomes.
  • Cyclodextrins (CDs) and chitosan (CS) offer potential for creating effective nanocarriers for antineoplastic drugs.

Purpose of the Study:

  • To review recent advancements in drug delivery systems utilizing chitosan or cyclodextrins for cancer management.
  • To highlight nanocarriers responsive to tumor microenvironment stimuli for targeted drug release.
  • To provide an overview of smart nanostructures in oncological therapies.

Main Methods:

  • Narrative review of English-language articles published between 2019 and 2025 in PubMed-indexed journals.
  • Focus on research involving encapsulation of antitumor drugs within chitosan or cyclodextrin-based nanosystems.
  • Analysis of stimuli-responsive drug release mechanisms (pH, redox, folate receptors).

Main Results:

  • Chitosan and cyclodextrin nanocarriers show promise in overcoming limitations of conventional chemotherapy.
  • Stimuli-responsive nanosystems enhance targeted delivery and release of anticancer drugs at tumor sites.
  • Recent research demonstrates significant advancements in nanostructures for cancer therapy.

Conclusions:

  • Smart drug delivery systems based on CDs and CS are vital for improving cancer treatment efficacy.
  • Targeted drug release mechanisms enhance therapeutic outcomes and minimize systemic toxicity.
  • Continued research into nanocarriers holds significant potential for future oncology therapies.

Related Concept Videos

Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
272
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
248
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K